Current opinion in endocrinology, diabetes, and obesity
Inhibition of angiopoietin-like protein 3 as a target for managing hypertriglyceridemia.
Pablo Corral, Natalia Nardelli, Laura Schreier
Published: 202510.1097/MED.0000000000000950
Abstract
PURPOSE OF REVIEW: To summarize recent advances in therapeutic strategies targeting angiopoietin-like protein 3 (ANGPTL3), a central regulator of triglyceride and remnant lipoprotein metabolism, and to discuss the potential of emerging pharmacologic…
Preview only. Read the full abstract at the source